Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2007-03-20
2007-03-20
Chen, Stacy B. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S214100, C424S204100, C424S222100, C424S234100, C424S093100, C424S464000, C435S005000
Reexamination Certificate
active
10167329
ABSTRACT:
The present invention relates to a stable compacted, compressed or hard tableted injectable composition, including a vaccine composition comprising at least one freeze dried antigenic component and a dissolution aid. A package containing the above injectable composition and method to facilitate immunizing a subject against a disease comprising the steps of first dissolving the compacted, compressed or hard tableted vaccine composition in a package with a diluent to form a vaccine solution, and administering the resulting vaccine solution in an amount effective for immunizing is also provided.
REFERENCES:
patent: 3317393 (1967-05-01), Chanock et al.
patent: 3458621 (1969-07-01), Tint
patent: 3603030 (1971-09-01), Tint
patent: 3893280 (1975-07-01), King et al.
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4235876 (1980-11-01), Gits et al.
patent: 4251509 (1981-02-01), Hanson et al.
patent: 4458630 (1984-07-01), Charma et al.
patent: 4578270 (1986-03-01), Csizer et al.
patent: 5178882 (1993-01-01), Kossovsky et al.
patent: 5206219 (1993-04-01), Desai
patent: 5336666 (1994-08-01), Neway et al.
patent: 5350741 (1994-09-01), Takads
patent: 5397569 (1995-03-01), Whitfill et al.
patent: 5472710 (1995-12-01), Klokkers-Bethke et al.
patent: RE35338 (1996-09-01), Haynes
patent: 5576014 (1996-11-01), Mizumoto et al.
patent: 5587180 (1996-12-01), Allen, Jr. et al.
patent: 5593697 (1997-01-01), Barr et al.
patent: 5631010 (1997-05-01), Mekalanos
patent: 5635210 (1997-06-01), Allen, Jr. et al.
patent: 5709861 (1998-01-01), Santiago et al.
patent: 5710041 (1998-01-01), Moorman et al.
patent: 5766602 (1998-06-01), Xiong et al.
patent: 5871748 (1999-02-01), Whitfill et al.
patent: 5897852 (1999-04-01), Wilderbeek et al.
patent: 6541001 (2003-04-01), Gallili et al.
patent: 6592869 (2003-07-01), Gallili et al.
patent: 2237783 (1974-02-01), None
patent: 117250 (1974-06-01), None
patent: 289200 (1976-01-01), None
patent: 106660 (1976-06-01), None
patent: 289201 (1999-04-01), None
patent: 298202 (1999-04-01), None
patent: 0290197 (1988-09-01), None
patent: 0905141 (1999-03-01), None
patent: 2082760 (1970-03-01), None
patent: 0929377 (1963-06-01), None
patent: 2 1 122 429 (1998-11-01), None
patent: WO 91/04749 (1991-04-01), None
patent: WO 9104757 (1991-04-01), None
patent: WO96/01874 (1996-01-01), None
patent: WO 9733531 (1997-09-01), None
patent: WO97/39762 (1997-10-01), None
patent: WO 9813029 (1998-04-01), None
patent: WO 9913869 (1999-03-01), None
patent: WO 9921579 (1999-05-01), None
patent: WO 9938529 (1999-08-01), None
patent: WO 00/48662 (2000-08-01), None
patent: WO 01/12797 (2001-02-01), None
Gallili et al., Newcastle Disease Vaccines, Biotechnology Advances, vol. 16, No. 2, pp. 343-366, 1998.
Worthington et al. (2000) Vaccine 21:1355-1362.
Embrex Inc. (2001) InOvation™ 1(1):1-2.
Fahey et al., (1992) Status of Immune-Based Therapies in HIV Infection and AIDS,Clin. Exp. Immunol. 88:1-5.
Fox, (1994) No Winners Against AIDS,Bio/Technology12:128.
Haynes et al., (1996) Update on the Issues of HIV Vaccine Development,Ann. Med. 28:39-41.
Mattson, Microscale Gas Chemistry: Experiments with Hydrogen Cholride, http://www.mattson.creighton.edu/HC1/,Apr. 21, 1998, see experiment 7 pp. 9-10 (Exhibit 1).
Cardamone, M., et al, “In Vitro Testing Of A Pulsatile Delivery System And Its In Vivo Application For Immunisation Against Tetanus Toxoid”, Journal Of Controlled Release, (1997) vol. 47, No. 3.
Haddad, E., et al., “Efficacy Of A Novel Infectious Bursal Disease Virus Immune Complex Vaccine In Broiler Chickens” Avian Diseases, (1997) vol. 41, No. 4, pp. 882-889.
Jeurissen, S., et al., “The Working Mechanism Of An Immune Complex Vaccine That Protects Chickens Against Infectious Bursal Disease”, Immunology, (1998) vol. 95, No. 3, pp. 494-500.
Johnston, P., et al., “Applications Inin ovoTechnology”, Poultry Science, (1997) vol. 76, No. 1, pp. 165-178.
Kelemen, M., et al., “Pathological And Immunological Study Of An In Ovo Complex Vaccine Against Infectious Bursal Disease”, Acta Veterinaria Hungarica, (2000), vol. 48, No. 4, pp. 443-454, Abstract only.
Supplemental European Search Report issued Feb. 28, 2005 in connection with European Application No. EP 02733085.1.
Frydman Norbert
Gallili Gilad
Chen Stacy B.
Cooper & Dunham LLP
Teva Pharmaceutical Industries Ltd.
White John P.
LandOfFree
Vaccine composition and method of using the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine composition and method of using the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine composition and method of using the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3722826